Cargando…
Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity
The conventional mono-chemotherapy still suffers from unsatisfied potency for cancer therapy due to tumor heterogeneity and the occurrence of drug resistance. Combination chemotherapy based on the nanosized drug delivery systems (nDDSs) has been developed as a promising platform to circumvent the li...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795977/ https://www.ncbi.nlm.nih.gov/pubmed/33375302 http://dx.doi.org/10.3390/polym13010067 |
_version_ | 1783634572125143040 |
---|---|
author | Zhang, Honglei Wu, Yanjuan Xu, Xiao Chen, Chen Xue, Xiukun Xu, Ben Li, Tianduo Chen, Zhaowei |
author_facet | Zhang, Honglei Wu, Yanjuan Xu, Xiao Chen, Chen Xue, Xiukun Xu, Ben Li, Tianduo Chen, Zhaowei |
author_sort | Zhang, Honglei |
collection | PubMed |
description | The conventional mono-chemotherapy still suffers from unsatisfied potency for cancer therapy due to tumor heterogeneity and the occurrence of drug resistance. Combination chemotherapy based on the nanosized drug delivery systems (nDDSs) has been developed as a promising platform to circumvent the limitations of mono-chemotherapy. In this work, starting from cisplatin and curcumin (Cur), we prepared a dual drug backboned shattering polymeric nDDS for synergistic chemotherapy. By in situ polymerization of the Cur, platinum (IV) complex-based prodrug monomer (DHP), L-lysine diisocyanate (LDI), and then conjugation with a hydrophilic poly (ethylene glycol) monomethyl ether (mPEG) derivative, a backbone-type platinum (IV) and Cur linkage containing mPEG-poly(platinum-co-Cur)-mPEG (PCPt) copolymer was synthesized. Notably, the platinum (IV) (Pt (IV)) and Cur were incorporated into the hydrophobic segment of PCPt with the fixed drugs loading ratio and high drugs loading content. The batch-to-batch variability could be decreased. The resulting prodrug copolymer then self-assembled into nanoparticles (PCPt NPs) with an average diameter around 100 nm, to formulate a synergetic nDDS. Importantly, PCPt NPs could greatly improve the solubility and stability of Cur. In vitro drug release profiles have demonstrated that PCPt NPs were stable in PBS 7.4, rapid burst release was greatly decreased, and the Pt and Cur release could be largely enhanced under reductive conditions due to the complete dissociation of the hydrophobic main chain of PCPt. In vitro cell viability test indicated that PCPt NPs were efficient synergistic chemotherapy units. Moreover, PCPt NPs were synergistic for cisplatin-resistant cell lines A549/DDP cells, and they exhibited excellent reversal ability of tumor resistance to cisplatin. This work provides a promising strategy for the design and synthesis of nDDS for combination chemotherapy. |
format | Online Article Text |
id | pubmed-7795977 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77959772021-01-10 Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity Zhang, Honglei Wu, Yanjuan Xu, Xiao Chen, Chen Xue, Xiukun Xu, Ben Li, Tianduo Chen, Zhaowei Polymers (Basel) Article The conventional mono-chemotherapy still suffers from unsatisfied potency for cancer therapy due to tumor heterogeneity and the occurrence of drug resistance. Combination chemotherapy based on the nanosized drug delivery systems (nDDSs) has been developed as a promising platform to circumvent the limitations of mono-chemotherapy. In this work, starting from cisplatin and curcumin (Cur), we prepared a dual drug backboned shattering polymeric nDDS for synergistic chemotherapy. By in situ polymerization of the Cur, platinum (IV) complex-based prodrug monomer (DHP), L-lysine diisocyanate (LDI), and then conjugation with a hydrophilic poly (ethylene glycol) monomethyl ether (mPEG) derivative, a backbone-type platinum (IV) and Cur linkage containing mPEG-poly(platinum-co-Cur)-mPEG (PCPt) copolymer was synthesized. Notably, the platinum (IV) (Pt (IV)) and Cur were incorporated into the hydrophobic segment of PCPt with the fixed drugs loading ratio and high drugs loading content. The batch-to-batch variability could be decreased. The resulting prodrug copolymer then self-assembled into nanoparticles (PCPt NPs) with an average diameter around 100 nm, to formulate a synergetic nDDS. Importantly, PCPt NPs could greatly improve the solubility and stability of Cur. In vitro drug release profiles have demonstrated that PCPt NPs were stable in PBS 7.4, rapid burst release was greatly decreased, and the Pt and Cur release could be largely enhanced under reductive conditions due to the complete dissociation of the hydrophobic main chain of PCPt. In vitro cell viability test indicated that PCPt NPs were efficient synergistic chemotherapy units. Moreover, PCPt NPs were synergistic for cisplatin-resistant cell lines A549/DDP cells, and they exhibited excellent reversal ability of tumor resistance to cisplatin. This work provides a promising strategy for the design and synthesis of nDDS for combination chemotherapy. MDPI 2020-12-26 /pmc/articles/PMC7795977/ /pubmed/33375302 http://dx.doi.org/10.3390/polym13010067 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhang, Honglei Wu, Yanjuan Xu, Xiao Chen, Chen Xue, Xiukun Xu, Ben Li, Tianduo Chen, Zhaowei Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity |
title | Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity |
title_full | Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity |
title_fullStr | Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity |
title_full_unstemmed | Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity |
title_short | Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity |
title_sort | synthesis characterization of platinum (iv) complex curcumin backboned polyprodrugs: in vitro drug release anticancer activity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795977/ https://www.ncbi.nlm.nih.gov/pubmed/33375302 http://dx.doi.org/10.3390/polym13010067 |
work_keys_str_mv | AT zhanghonglei synthesischaracterizationofplatinumivcomplexcurcuminbackbonedpolyprodrugsinvitrodrugreleaseanticanceractivity AT wuyanjuan synthesischaracterizationofplatinumivcomplexcurcuminbackbonedpolyprodrugsinvitrodrugreleaseanticanceractivity AT xuxiao synthesischaracterizationofplatinumivcomplexcurcuminbackbonedpolyprodrugsinvitrodrugreleaseanticanceractivity AT chenchen synthesischaracterizationofplatinumivcomplexcurcuminbackbonedpolyprodrugsinvitrodrugreleaseanticanceractivity AT xuexiukun synthesischaracterizationofplatinumivcomplexcurcuminbackbonedpolyprodrugsinvitrodrugreleaseanticanceractivity AT xuben synthesischaracterizationofplatinumivcomplexcurcuminbackbonedpolyprodrugsinvitrodrugreleaseanticanceractivity AT litianduo synthesischaracterizationofplatinumivcomplexcurcuminbackbonedpolyprodrugsinvitrodrugreleaseanticanceractivity AT chenzhaowei synthesischaracterizationofplatinumivcomplexcurcuminbackbonedpolyprodrugsinvitrodrugreleaseanticanceractivity |